Glenmark to launch generic medication in US

[ad_1] New Delhi, Glenmark Pharmaceuticals on Thursday said it will launch a generic medication this month in the US market for the treatment of anaemia and to prevent serious side effects caused by large doses of medications that can reduce the impact of folic acid in the body. Glenmark Pharmaceuticals Inc., USA, a unit of…

Read More

Glenmark launches fixed-dose triple therapy for COPD

[ad_1] Glenmark Pharmaceuticals on Tuesday said it has launched the world’s first nebulised, fixed-dose triple therapy for the treatment of chronic obstructive pulmonary disease. Nebzmart GFB Smartules and Airz FB Smartules combine three proven medicines – Glycopyrronium, Formoterol, and Budesonide – to reduce airway obstruction, inflammation, and improve lung function and symptom control, the Mumbai-based…

Read More

Glenmark, Dr Reddy’s recall products in US: USFDA

[ad_1] Drugmakers Glenmark and Dr Reddy’s Laboratories are recalling products in the US due to manufacturing issues, according to the US Food and Drug Administration (USFDA). As per its latest Enforcement Report, the US health regulator noted that a US-based unit of Glenmark Pharmaceuticals is recalling 26,928 packs of oral contraceptive medication in the US….

Read More

Indian Pharmaceutical Alliance appoints Zydus Lifesciences MD Sharvil Patel as new president

[ad_1] The Indian Pharmaceutical Alliance (IPA) has appointed Sharvil Patel, Managing Director of Zydus Lifesciences as its new President. Patel succeeds Samir Mehta, Chairman, Torrent Group, the industry body said in an announcement on Friday. The IPA leadership team also includes Glenn Saldanha, Chairman and Managing Director, Glenmark, who has been appointed as Vice President….

Read More